GlaxoSmithKline to cease providing corporate political contributions
GlaxoSmithKline today announced a new global policy to voluntarily stop all corporate political contributions. In the past, GSK in common with many companies and in full compliance with local laws has made a number of corporate contributions in countries such as the US and Canada. GSKs new policy will ensure that no such contributions will be made in the future.
We continue to believe that it is important for GSK to be engaged in policy debates and the political process. However, we need to ensure that there is no implication whatsoever that corporate political contributions provide us with any special privileges. We do not believe they have, and in the few countries we have given contributions we have done so in full compliance of the law. As part of our overall drive to improve transparency in terms of our interactions with governments, political leaders and candidates for public office, we believe that stopping corporate political contributions is the right thing to do. Our focus is, as it always has been, on helping governments by providing them with evidence that our medicines and vaccines provide a strong value proposition, said Andrew Witty, CEO, GlaxoSmithKline.
In the US, the company will continue to support a voluntary and independent Political Action Committee (PAC) to facilitate political contributions by eligible GSK employees.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.